BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35205852)

  • 21. A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Feys S; Almyroudi MP; Braspenning R; Lagrou K; Spriet I; Dimopoulos G; Wauters J
    J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
    Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
    Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
    Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
    Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
    J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
    Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
    Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.
    Lackner N; Thomé C; Öfner D; Joannidis M; Mayerhöfer T; Arora R; Samardzic E; Posch W; Breitkopf R; Lass-Flörl C
    J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19-Associated Pulmonary Aspergillosis in Russia.
    Shadrivova O; Gusev D; Vashukova M; Lobzin D; Gusarov V; Zamyatin M; Zavrazhnov A; Mitichkin M; Borzova Y; Kozlova O; Desyatik E; Burygina E; Ignatyeva S; Oganesyan E; Vasilyeva N; Klimko N; Working Group
    J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practice Guidelines for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis in an Intensive Care Setting.
    Hashim Z; Neyaz Z; Marak RSK; Nath A; Nityanand S; Tripathy NK
    J Intensive Care Med; 2022 Aug; 37(8):985-997. PubMed ID: 34678103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold.
    Lupia T; Montrucchio G; Gaviraghi A; Musso G; Puppo M; Bolla C; Shbaklo N; Rizzello B; Della Selva A; Concialdi E; Rumbolo F; Barbui AM; Brazzi L; De Rosa FG; Corcione S
    J Fungi (Basel); 2022 Nov; 8(12):. PubMed ID: 36547597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
    Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
    J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study.
    Xu J; Yang X; Lv Z; Zhou T; Liu H; Zou X; Cao F; Zhang L; Liu B; Chen W; Yu Y; Shu H; Yuan S; Hu M; Huang C; Shang Y
    Front Med (Lausanne); 2021; 8():753659. PubMed ID: 34869450
    [No Abstract]   [Full Text] [Related]  

  • 34. Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
    Reizine F; Pinceaux K; Lederlin M; Autier B; Guegan H; Gacouin A; Luque-Paz D; Boglione-Kerrien C; Bacle A; Le Daré B; Launey Y; Lesouhaitier M; Painvin B; Camus C; Mansour A; Robert-Gangneux F; Belaz S; Le Tulzo Y; Tadié JM; Maamar A; Gangneux JP
    J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34063556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
    Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
    Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital.
    Ranhel D; Ribeiro A; Batista J; Pessanha M; Cristovam E; Duarte A; Dias A; Coelho L; Monteiro F; Freire P; Veríssimo C; Sabino R; Toscano C
    J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions.
    Egger M; Bussini L; Hoenigl M; Bartoletti M
    J Fungi (Basel); 2022 Apr; 8(4):. PubMed ID: 35448621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covid-19 associated pulmonary aspergillosis with extensive cavitary pneumonia: A case report.
    Hanif S; Iqbal M; Sethi SM
    J Pak Med Assoc; 2023 Jan; 73(1):174-176. PubMed ID: 36842034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients.
    Hashim Z; Nath A; Khan A; Neyaz Z; Marak RSK; Areekkara P; Tiwari A; Srivastava S; Agarwal V; Saxena S; Tripathy N; Azim A; Gupta M; Mishra DP; Mishra P; Singh RK; Gupta D; Gupta A; Sanjeev OP; Ghatak T; Ghoshal U; Dhiman RK; Tripathy NK
    Mycoses; 2022 Nov; 65(11):1010-1023. PubMed ID: 35716344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman.
    Agrawal S; Phulware RH
    Autops Case Rep; 2021; 11():e2021313. PubMed ID: 34458181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.